Core Points - The company, Shandong Zhongnong United Biotechnology Co., Ltd., is announcing a delay in the election of its fourth board of directors and supervisory board, which is set to expire on August 15, 2025 [1] - The delay is part of the company's governance structure reform and aims to ensure continuity and stability in the operations of the board and supervisory board [1] - The current members of the board and senior management will continue to fulfill their duties and obligations until the new elections are completed [1] Company Operations - The delay in the board election will not affect the normal operations of the company [1] - The company is committed to actively advancing the board election process and will fulfill its information disclosure obligations in a timely manner [1]

Core Viewpoint - The company is announcing a delay in the board of directors' re-election due to the incomplete nomination process for new candidates, while ensuring that normal operations will not be affected [1]. Group 1: Board of Directors - The current term of the eighth board of directors will expire on August 16, 2025 [1]. - The delay in the board re-election is in line with the implementation of the Company Law and the latest regulatory requirements [1]. - The terms of the board's specialized committees will also be extended accordingly [1]. Group 2: Governance and Compliance - The company is advancing its corporate governance structure reform [1]. - The current board will continue to fulfill its responsibilities according to legal regulations and the company's articles of association until the re-election process is completed [1]. - The company commits to promptly advancing the board re-election process and fulfilling relevant information disclosure obligations [1].